Focus Diagnostics Home
 Home  About Focus Diagnostics  Employment  Contact Us
Test Listing New Tests Test Updates Certifications Client Services Account Setup Contact Us
 
Click the controls at right to expand & collapse the search function Open the search function Close the search function
Please select the first letter of the test you are interested in viewing or
click NEW for a complete listing of our newest assays.
Enter Test Name(s) / Code(s): Test Title Description Category Search:
 
All words must appear Any word can appear    
Reference Laboratory
Tests
 
20775
21-Hydroxylase Antibody print

The microsomal enzyme 21-hydroxylase is the major autoantigen recognized by adrenal cortex autoantibodies, found in chronic primary adrenal insufficiency (Addison’s disease). Autoantibodies to 21-hydroxylase are found in approximately 70% of patients with isolated Addison’s disease, >90% of patients with Addison’s disease as part of autoimmune poyglandular syndrome, and 1 to 5% of patients with other autoimmune endocrine diseases.

*This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Focus Diagnostics. This test should not be used for diagnosis without confirmation by other medically established means.

Test performed at Quest Diagnostics Nichols Institute.

RIA (Radioimmunoassay)
<1 U/mL
1 mL serum
(minimum 0.2 mL)
2-8° C
3 to 29 days
83519*
 
51590
5-Fluorocytosine Level, BA print

Specimens collected just before or within 15 minutes of the next dose represent the TROUGH levels. Specimens obtained within 15-30 minutes after the end of I.V. infusion or 45-60 minutes after an IM injection or 90 minutes after oral intake represent the PEAK level.

Therapeutic levels:
 Peak serum30-45 mcg/mL

List all other antimicrobials being used to treat the patient.

This test is available for New York patient testing.

Bioassay
By report
1 mL serum
(minimum 0.5 mL)
Red Top serum separator tubes not acceptable.
FROZEN
3 to 5 days
80299
 
 
First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics


FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics’ Focus Diagnostics


Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.


Focus Diagnostics receives NYSDOH exemption for Diagnostic Immunology and Serology testing services


Focus Diagnostics Launches Laboratory Test for Chikungunya Virus


 
   
Back to top  
   
©2010 - Focus Diagnostics - All Rights Reserved - Site Revision ID: WEB.FOCUSDX.C3 - Privacy Policy - Site Map